StemCells, Inc. (STEM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalData
36 Pages - GLDATA55916
$250.00

Summary

StemCells, Inc. (StemCells), a subsidiary of Stem Cell Sciences UK Ltd is a pharmaceutical company that conducts research, develops and commercializes cell based therapeutics and related tools. It provides research on products for spinal cord injury, thoracic injury, cervical injury, retinal disorders, dry age-related macular degeneration, neurodegenerative diseases, neuronal ceroid lipofuscinosis, and pelizaeus-merzbacher disease. StemCells provides clinical development of proprietary HuCNS-SC purified human neural stem cells platform technology for the treatment of human central nervous system. Its products are used in stem cell-based drug discovery and research. The company also operates in Switzerland. StemCells is headquartered in Newark, California, the US.

StemCells, Inc. (STEM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
StemCells, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
StemCells, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
StemCells, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
StemCells, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
StemCells, Inc., Medical Devices Deals, 2010 to YTD 2016 9
StemCells, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
StemCells, Inc., Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
StemCells Acquires Seminal Neural Stem Cell Patent Portfolio From NeuroSpheres 11
Partnerships 12
StemCells Enters Into Agreement With R Biomedical To Develop Reagents For Human iPS Cell Research 12
Licensing Agreements 13
StemCells Enters Into Licensing Agreement With genOway For Internal Ribosome Entry Site Technology 13
StemCells Enters Into Licensing Agreement With Children's Hospital of Orange County 14
Equity Offering 15
StemCells Raises USD8 Million in Public Offering of Shares and Warrants 15
StemCells Completes Exercise of Underwriter's Over Allotment Option for Public Offering of Shares and Warrants for USD27 Million 17
StemCells Raises USD20 Million in Private Placement of Units 19
StemCells Files Registration Statement For IPO To Raise Up To US$100 Million 21
StemCells Terminates Private Placement Of Shares For US$31 Million 22
StemCells Completes Public Offering Of Units For US$18.6 Million 24
StemCells Completes Public Offering Of Shares For US$1.6 Million 25
StemCells Completes Public Offering Of Units For US$10 Million 27
StemCells Completes Private Placement Of Its Common Stock For US$10 Million 29
StemCells Completes Private Placement For US$6 Million 31
StemCells, Inc. - Key Competitors 33
Key Employees 34
Locations And Subsidiaries 35
Head Office 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
StemCells, Inc., Pharmaceuticals & Healthcare, Key Facts, 2014 1
StemCells, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
StemCells, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
StemCells, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
StemCells, Inc., Deals By Therapy Area, 2010 to YTD 2016 8
StemCells, Inc., Medical Devices Deals, 2010 to YTD 2016 9
StemCells, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
StemCells Acquires Seminal Neural Stem Cell Patent Portfolio From NeuroSpheres 11
StemCells Enters Into Agreement With R Biomedical To Develop Reagents For Human iPS Cell Research 12
StemCells Enters Into Licensing Agreement With genOway For Internal Ribosome Entry Site Technology 13
StemCells Enters Into Licensing Agreement With Children's Hospital of Orange County 14
StemCells Raises USD8 Million in Public Offering of Shares and Warrants 15
StemCells Completes Exercise of Underwriter's Over Allotment Option for Public Offering of Shares and Warrants for USD27 Million 17
StemCells Raises USD20 Million in Private Placement of Units 19
StemCells Files Registration Statement For IPO To Raise Up To US$100 Million 21
StemCells Terminates Private Placement Of Shares For US$31 Million 22
StemCells Completes Public Offering Of Units For US$18.6 Million 24
StemCells Completes Public Offering Of Shares For US$1.6 Million 25
StemCells Completes Public Offering Of Units For US$10 Million 27
StemCells Completes Private Placement Of Its Common Stock For US$10 Million 29
StemCells Completes Private Placement For US$6 Million 31
StemCells, Inc., Key Competitors 33
StemCells, Inc., Key Employees 34

List of Figures
StemCells, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
StemCells, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
StemCells, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
StemCells, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
StemCells, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
StemCells, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
StemCells, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
StemCells, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
StemCells, Inc., Medical Devices Deals, 2010 to YTD 2016 9

$250.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838